Photophobia in Levothroid - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Photophobia, when it was recovered, drug effectiveness, race, and more among people who take Levothroid (levothyroxine sodium). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,974 Levothroid users. Check the latest studies of Levothroid.

What is Photophobia?

Photophobia (extreme sensitivity to light) is found to be associated with 1,290 drugs and 1,831 conditions by eHealthMe. Check the latest studies of Photophobia.

On Jul, 28, 2026

25 people who have Photophobia while taking Levothroid were studied.

Severity of Photophobia *:

least: 4.76 %
moderate: 47.62 %
severe: 33.33 %
most severe: 14.29 %

When people recovered from Photophobia *:

while on drug: 0.0 %
after off the drug: 5.56 %
not yet: 94.44 %

Effectiveness of Levothroid *:

not at all: 0.0 %
somewhat: 31.58 %
moderate: 26.32 %
high: 26.32 %
very high: 15.79 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 4.76 %
Hispanic: 4.76 %
Native Hawaiians/Pacific Islanders: 4.76 %
Two or more races: 0.0 %
White, Non-Hispanic: 85.71 %

Time on Levothroid *:

Gender of people when taking Levothroid *:

female: 100 %
male: 0.0 %

Age of people when taking Levothroid *:

Conditions people have *:

Depression: 5 people, 20.00%
Allergies: 4 people, 16.00%
High Blood Pressure: 3 people, 12.00%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 12.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.00%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 3 people, 12.00%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 8.00%
Asthma: 2 people, 8.00%
High Blood Cholesterol: 2 people, 8.00%
Migraine (headache): 2 people, 8.00%

Other drugs people take besides Levothroid *:

Vitamin D: 4 people, 16.00%
Sertraline: 3 people, 12.00%
Zyrtec: 2 people, 8.00%
Citalopram Hydrobromide: 2 people, 8.00%
Omeprazole: 2 people, 8.00%
Topamax: 2 people, 8.00%
Fioricet: 1 person, 4.00%
Elavil: 1 person, 4.00%
Escitalopram: 1 person, 4.00%
Famotidine: 1 person, 4.00%

Other side effects people have besides Photophobia *:

Dizziness: 5 people, 20.00%
Fatigue (feeling of tiredness): 4 people, 16.00%
Vision Problems: 4 people, 16.00%
Diarrhea: 4 people, 16.00%
Cold Intolerance: 3 people, 12.00%
Migraine (headache): 3 people, 12.00%
Stress And Anxiety: 3 people, 12.00%
Headache (pain in head): 3 people, 12.00%
Tinnitus (a ringing in the ears): 3 people, 12.00%
Dry Eyes (lack of adequate tears): 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Levothroid and have Photophobia?

Check whether Photophobia is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Photophobia in Levothroid

How the study uses the data?

The study is based on levothyroxine sodium (the active ingredients of Levothroid). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.